Table 4.
Changes in kidney function over time.
Measurement | Follow-up Duration (mo) |
Group | Rate of Change in Kidney Function |
P |
---|---|---|---|---|
mGFR (mL/min per y) | 12–36 | Controls | −0.36±7.55 (194) | 0.005 |
Donors | 1.47±5.02 (198) | |||
36 | Controls | −0.19±5.31 (172) | 0.002 | |
Donors | 1.30±3.49 (181) | |||
mGFR (mL/min/1.73 m2 per y) | 12–36 | Controls | −0.44±7.35 (194) | 0.01 |
Donors | 1.09±4.28 (198) | |||
36 | Controls | −0.39±4.81 (172) | 0.004 | |
Donors | 0.84±3.09 (181) | |||
eGFRcr (mL/min/1.73 m2 per y) | 12–36 | Controls | −1.04±6.16 (196) | <0.001 |
Donors | 1.82±4.92 (200) | |||
36 | Controls | −0.46±3.68 (173) | <0.001 | |
Donors | 1.60±3.75 (182) | |||
eGFRcys (mL/min/1.73 m2 per y) | 12–36 | Controls | −0.33±7.36 (196) | 0.003 |
Donors | 1.82±6.76 (200) | |||
36 | Controls | 0.16±4.68 (173) | 0.04 | |
Donors | 1.21±5.06 (182) | |||
eGFRcr-cys (mL/min/1.73 m2 per y) | 12–36 | Controls | −0.73±6.38 (196) | <0.001 |
Donors | 1.89±4.58 (200) | |||
36 | Controls | −0.07±3.85 (173) | <0.001 | |
Donors | 1.49±3.81 (182) |
Note: Unless otherwise indicated, changes in kidney function over time (“slopes”).are given as mean ± standard deviation (number sampled). Shown are slopes with and without dropping cases that did not have a 36 month visit.
Abbreviations and definitions: CysC, cystatin C; eGFRcr, estimated glomerular filtration rate calculated by Chronic Kidney Disease Epidemiology Collaboration creatinine equation; eGFRcr-cys, estimated glomerular filtration rate calculated by Chronic Kidney Disease Epidemiology Collaboration creatinine-cystatin C equation; eGFRcys, estimated glomerular filtration rate calculated by Chronic Kidney Disease Epidemiology Collaboration cystatin C equation; mGFR, glomerular filtration rate measured by iohexol plasma clearance.
T-test.